Cargando…

Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy

Lehmann et al have identified four molecular subtypes of triple-negative breast cancer (TNBC)—basal-like (BL) 1, BL2, mesenchymal (M), and luminal androgen receptor—and an immunomodulatory (IM) gene expression signature modifier. Our group previously showed that the response of TNBC to neoadjuvant s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuda, Hiroko, Harano, Kenichi, Miura, Sakiko, Wang, Ying, Hirota, Yuko, Harada, Oi, Jolly, Mohit Kumar, Matsunaga, Yuki, Lim, Bora, Wood, Anita L., Parinyanitikul, Napa, Jin Lee, Hee, Gong, Gyungyub, George, Jason T., Levine, Herbert, Lee, Jangsoon, Wang, Xiaoping, Lucci, Anthony, Rao, Arvind, Schweitzer, Brock L., Lawrence, O. Rayne, Seitz, Robert S., Morris, Stephan W., Hout, David R., Nakamura, Seigo, Krishnamurthy, Savitri, Ueno, Naoto T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2022
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939918/ https://www.ncbi.nlm.nih.gov/pubmed/35294223 http://dx.doi.org/10.1200/PO.20.00368

Ejemplares similares

Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research
por: Espinosa Fernandez, Jose Rodrigo, et al.
Publicado: (2020)

cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer
por: Sohn, Joohyuk, et al.
Publicado: (2014)

Lactic acidosis, a potential toxicity from drug–drug interaction related to concomitant ribociclib and metformin in preexisting renal insufficiency: A case report
por: Lagampan, Chalita, et al.
Publicado: (2021)

Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis
por: Su, Fei, et al.
Publicado: (2020)

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
por: Harano, Kenichi, et al.
Publicado: (2018)

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
por: Iwase, Toshiaki, et al.
Publicado: (2020)

Development and validation of a rapid psychosocial well-being screening tool in patients with metastatic breast cancer
por: Thanasansomboon, Bhumipat, et al.
Publicado: (2022)

Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer
por: Lee, Jangsoon, et al.
Publicado: (2015)

A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies
por: Nielsen, Tyler J., et al.
Publicado: (2021)

Tumor mutational profile of triple negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodeling gene
por: Niyomnaitham, Suvimol, et al.
Publicado: (2019)

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer
por: Kida, Kumiko, et al.
Publicado: (2020)

The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer
por: Ning, Jing, et al.
Publicado: (2019)

Novel Anti-FOLR1 Antibody–Drug Conjugate MORAb-202 in Breast Cancer and Non-Small Cell Lung Cancer Cells
por: Matsunaga, Yuki, et al.
Publicado: (2021)

ONC201 and an MEK Inhibitor Trametinib Synergistically Inhibit the Growth of Triple-Negative Breast Cancer Cells
por: Lim, Bora, et al.
Publicado: (2021)

Circulating tumor cells in non-metastatic triple-negative breast cancer
por: Karhade, Mandar, et al.
Publicado: (2014)

A gene signature consisting of ubiquitin ligases and deubiquitinating enzymes of SKP2 is associated with clinical outcome in breast cancer
por: Fong, Lon W. R., et al.
Publicado: (2022)

Aldehyde Dehydrogenase1 Immunohistochemical Staining in Primary Breast Cancer Cells Independently Predicted Overall Survival But Did Not Correlate with the Presence of Circulating or Disseminated Tumors Cells
por: Woodward, Wendy A., et al.
Publicado: (2014)

PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening
por: Lee, Jangsoon, et al.
Publicado: (2021)

A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer
por: Iwase, Toshiaki, et al.
Publicado: (2021)

Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories
por: Ithimakin, Suthinee, et al.
Publicado: (2022)

Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer
por: Krishnamurthy, Savitri, et al.
Publicado: (2013)

Association of cyclooxygenase-2 expression with endoplasmic reticulum stress and autophagy in triple-negative breast cancer
por: Lee, Haechan, et al.
Publicado: (2023)

Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
por: Ring, Brian Z., et al.
Publicado: (2016)

Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
por: Ring, Brian Z., et al.
Publicado: (2016)

Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer
por: Yamauchi, Teruo, et al.
Publicado: (2018)

Ultrasound guided fine needle aspiration biopsy of parathyroid gland and lesions
por: Dimashkieh, Haytham, et al.
Publicado: (2006)

Feasibility of using digital confocal microscopy for cytopathological examination in clinical practice
por: Krishnamurthy, Savitri, et al.
Publicado: (2021)

Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
por: Xie, Xuemei, et al.
Publicado: (2023)

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance
por: Yamazaki, Chisato M., et al.
Publicado: (2021)

Functional consequence of the MET-T1010I polymorphism in breast cancer
por: Liu, Shuying, et al.
Publicado: (2014)

Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue
por: Jovanović, Bojana, et al.
Publicado: (2017)

Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembrolizumab
por: Saltman, David L., et al.
Publicado: (2021)

Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype
por: Funakoshi, Yohei, et al.
Publicado: (2019)

Comment on ‘Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques'
por: Kuerer, Henry M, et al.
Publicado: (2016)

Ultrastructural Analysis of Inflammatory Breast Cancer Cell Clusters in an Ex Vivo Environment Mechanically Mimicking the Lymph Vascular System
por: Fujii, Yuka, et al.
Publicado: (2021)

Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
por: Krishnamurthy, Savitri, et al.
Publicado: (2013)

BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ
por: Liu, Yan, et al.
Publicado: (2019)

Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center
por: Fouad, Tamer M., et al.
Publicado: (2018)

Distinguishability of keystroke dynamic template
por: Sae-Bae, Napa, et al.
Publicado: (2022)

International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference
por: Ueno, Naoto T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8h1ostv7rb2q0riiojhhdt1gmd